Virtus Investment Advisers, Inc. Igm Biosciences, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $289 Million
- Q1 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 19,974 shares of IGMS stock, worth $24,368. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,974Holding current value
$24,368% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$3.97 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.6 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.07 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $35.3M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...